EX-99.1 2 xene-ex991_6.htm EX-99.1 xene-ex991_6.htm

Exhibit 99.1

 

Craig Colosso

Relationship Manager

 

American Stock Transfer & Trust Company, LLC

Charlotte, North Carolina

 

Tel: 718.921.8337

Email: ccolosso@amstock.com

www.amstock.com

 

 

 

 

 

March 13, 2019

 

 

 

Alberta Securities Commission

 

 

British Columbia Securities Commission

 

 

Ontario Securities Commission

 

 

 

 

RE:  Xenon Pharmaceuticals Inc.

 

Pursuant to a request from the above-mentioned reporting issuer, we wish to advise you of the following information in connection with its Annual Meeting of Shareholders:

 

Date of meeting:

June 3, 2019

Record date for notice:

April 8, 2019

Record date for voting:

April 8, 2019

Beneficial ownership determination date:

April 8, 2019

Securities entitled to notice:

Common Shares and Series 1 Preferred Shares

Securities entitled to vote:

Common Shares and Series 1 Preferred Shares

Issuer mailing directly to non objecting beneficial owners:

No

Issuer will pay for objecting beneficial owner material distribution:

Yes

Issuer using notice-and-access for registered investors:

No

Issuer using notice-and-access for non-registered investors:

No

Notice-and-access stratification criteria:

N/A

 

 

Yours very truly,

 

/s/ Craig Colosso

 

Craig Colosso

Relationship Manager